Rezq Bio
PrivateLast Round
Accelerator
Jun 15, 2023
Company Overview
Rezq Bio is a biotechnology company that develops dendritic cell therapy for the treatment of Type 1 diabetes and other localized autoimmune conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rezq Bio Comparables
Compare Rezq Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cell4Cure AB | 86% | |
| Avotres Inc. | 85% | |
| SymbioCellTech | 72% | |
Rezq Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 15, 2023 |
Rezq Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartUp Health | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 15, 2023
Secured funding from StartUp Health.
Rezq Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rezq Bio's valuation, stock price, and market status.